Digoxin Pregnancy and Breastfeeding Warnings
Digoxin Pregnancy Warnings
There are no reports of congenital defects associated with digoxin. Digoxin crosses the placenta with increasing fetal accumulation throughout gestation. Umbilical cord concentrations reported have been 50%, 81%, and 83% of maternal serum levels. The fetal heart has a limited ability to bind digoxin during the first half of human gestation, but concentrates digoxin in the second half. Fetal and neonatal tolerance is greater (2 to 4 ng/mL) than that of adults (less than 2 ng/mL). Monitoring of serum digoxin levels, both antepartum and postpartum, is recommended as maternal plasma clearance of digoxin is significantly increased during pregnancy.
Digoxin has been assigned to FDA pregnancy category C by the FDA. Animal studies failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy. Digoxin has been used successfully to treat maternal congestive heart failure and arrhythmias and fetal arrhythmias throughout gestation without reports of fetal harm, however, digoxin should be given during pregnancy only when benefit outweighs risk.
Digoxin Breastfeeding Warnings
Digoxin is excreted into human milk, however, nursing infant exposure is limited. Pharmacologic and/or adverse effects are not anticipated. However, the manufacturer recommends caution when administering digoxin to nursing women.
Digoxin milk to maternal serum concentration ratios of 0.6 to 0.9 have been reported. Data from two women taking digoxin 0.25 mg daily revealed mean peak digoxin milk levels of 0.61 to 0.96 ng/mL at 4 and 6 hours after dosing, respectively. The mean digoxin milk levels in these two patients were 0.78 and 0.41 ng/mL, respectively. Digoxin could not be detected in the plasma of either nursing infant (radioimmunoassay sensitivity of 0.1 ng/mL). The authors calculated that should the nursing infants consume 150 mL of milk/kg/day, the digoxin burden would be 0.12 and 0.06 mcg/kg/day, respectively. These amounts are associated with subtherapeutic neonatal levels. A case in which a mean milk digoxin level of 1.9 ng/mL was similar to the maternal plasm level has been reported. The mother was taking digoxin 0.75 mg daily. This milk digoxin level is considerably higher than other levels reported, however, the digoxin burden to the nursing infant was reported as 0.2 ng/mL.
- Digoxin use while Breastfeeding (in more detail)
- Digoxin Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.